PReS-FINAL-2142: Predictors of persistent remission following etanercept (ETN) withdrawal in patients with juvenile idiopathic arthritis (JIA)

被引：0
|
作者：
F Perfetti
F Gesualdo
V Messia
A Insalaco
C Bracaglia
M Pardeo
R Nicolai
L Meli
F De Benedetti
S Magni Manzoni
机构：
[1] Pediatric Rheumatology Unit,Epidemiology Unit
[2] IRCCS Bambino Gesù Children's Hospital,undefined
来源：
Pediatric Rheumatology | / 11卷 / Suppl 2期
关键词：
Disease Duration; Etanercept; Juvenile Idiopathic Arthritis; Disease Onset; Active Joint;
D O I：
10.1186/1546-0096-11-S2-P154
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] PReS-FINAL-2096: Herpes virus infections in patients with juvenile idiopathic arthritis (JIA) treated with etanercept
    R Nicolai
    E Cortis
    L Ravà
    C Bracaglia
    M Pardeo
    A Insalaco
    PS Buonuomo
    F De Benedetti
    AE Tozzi
    [J]. Pediatric Rheumatology, 11 (Suppl 2)
  • [2] PReS-FINAL-2170: Work disability in adult patients with juvenile idiopathic arthritis (JIA)
    C Goldenstein-Schainberg
    J Gordo
    R Krieger
    LE Paula
    N Aikawa
    [J]. Pediatric Rheumatology, 11 (Suppl 2)
  • [3] JUVENILE IDIOPATHIC ARTHRITIS (JIA); HOW DO CLINICIANS DEFINE REMISSION AND WITHDRAW ETANERCEPT?
    Broughton, T.
    Armon, K.
    [J]. PEDIATRIC RESEARCH, 2010, 68 : 86 - 86
  • [4] PReS-FINAL-2003: Remission and predictors of persistent disease activity at 30 years follow-up in a Norwegian cohort of juvenile idiopathic arthritis patients
    AM Selvaag
    HA Aulie
    V Lilleby
    B Flatø
    [J]. Pediatric Rheumatology, 11 (Suppl 2)
  • [5] Predictors of Flare Following Etanercept Withdrawal in Patients with Rheumatoid Factor-negative Juvenile Idiopathic Arthritis Who Reached Remission while Taking Medication
    Aquilani, Angela
    Marafon, Denise Pires
    Marasco, Emiliano
    Nicolai, Rebecca
    Messia, Virginia
    Perfetti, Francesca
    Magni-Manzoni, Silvia
    De Benedetti, Fabrizio
    [J]. JOURNAL OF RHEUMATOLOGY, 2018, 45 (07) : 956 - 961
  • [6] PReS-FINAL-2062: The need for conducting different rehabilitation complexes for patients with juvenile idiopathic arthritis (JIA)
    TA Shelepina
    IP Nikishina
    [J]. Pediatric Rheumatology, 11 (Suppl 2)
  • [7] 165 Juvenile Idiopathic Arthritis (JIA); How Do Clinicians Define Remission and Withdraw Etanercept?
    T Broughton
    K Armon
    [J]. Pediatric Research, 2010, 68 : 86 - 86
  • [8] Safety and Efficacy of Etanercept in 2000 Patients with Juvenile Idiopathic Arthritis (JIA) in the JIA Biologics Register
    Horneff, Gerd
    Brunner, Juergen
    Haas, Johannes Peter
    Ganser, Gerd
    Foeldvari, Ivan
    Hospach, Toni
    Minden, Kirsten
    Huppertz, Hans-Iko
    Kuester, Rolf M.
    Trauzeddel, Ralf
    Thon, Angelika
    [J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [9] Long-term safety of Etanercept in patients with juvenile idiopathic arthritis (JIA)
    Minden, K.
    Klotsche, J.
    Niewerth, M.
    Horneff, G.
    [J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 : 13 - 13
  • [10] Long-Term Safety of Etanercept in Patients with Juvenile Idiopathic Arthritis (JIA)
    Minden, Kirsten
    Niewerth, Martina
    Klotsche, Jens
    Hammer, Michael
    Haas, Johannes Peter
    Ganser, Gerd
    Horneff, Gerd
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S493 - S493
12345